COSMOS Pharmaceutical Corporation

Tokyo Stock Exchange 3349.T

COSMOS Pharmaceutical Corporation EBT Margin for the year ending May 31, 2024: 3.49%

COSMOS Pharmaceutical Corporation EBT Margin is 3.49% for the year ending May 31, 2024, a -11.75% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

COSMOS Pharmaceutical Corporation EBT Margin for the year ending May 31, 2023 was 3.96%, a -9.49% change year over year.
COSMOS Pharmaceutical Corporation EBT Margin for the year ending May 31, 2022 was 4.37%, a -17.66% change year over year.
COSMOS Pharmaceutical Corporation EBT Margin for the year ending May 31, 2021 was 5.31%, a 19.61% change year over year.
COSMOS Pharmaceutical Corporation EBT Margin for the year ending May 31, 2020 was 4.44%, a 0.03% change year over year.

Key data

Date	EBT Margin	Net Income Margin	EBITDA Margin	EBIT Margin

Tokyo Stock Exchange: 3349.T

COSMOS Pharmaceutical Corporation

CEO	Mr. Hideaki Yokoyama
IPO Date	Nov. 11, 2004
Location	Japan
Headquarters	Fukuoka Daiichi Building
Employees	5,512
Sector	Health Care
Industries Drugstores & Retail Pharmacies Pharmaceuticals Specialty Retail

Description

COSMOS Pharmaceutical Corporation operates a chain of drug stores in Japan. It also operates 1,130 stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions. The company was founded in 1983 and is headquartered in Fukuoka, Japan.

Key trends

Past 5 years